These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3460693)

  • 1. Mechanism of macrophage reversal of Friend erythroleukemia: macrophage regulation of normal and leukemic erythropoiesis.
    Johnson CS; Thurlow SM; Marcelletti JF; Furmanski P
    Cancer Res; 1986 Aug; 46(8):3896-902. PubMed ID: 3460693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of normal erythropoiesis in vitro by macrophages from erythroleukemic mice.
    Johnson CS; Marcelletti J; Furmanski P
    J Natl Cancer Inst; 1984 Feb; 72(2):491-6. PubMed ID: 6582332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
    Marcelletti J; Furmanski P
    J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
    Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
    Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor.
    Furmanski P; Johnson CS
    Blood; 1990 Jun; 75(12):2328-34. PubMed ID: 2350578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic approaches to leukemia: the use of the Friend virus-induced erythroleukemia model system.
    Johnson CS; Chang MJ; Thurlow SM; Pourbohloul SC; Furmanski P
    Cancer Res; 1990 Sep; 50(17 Suppl):5682S-5686S. PubMed ID: 2117483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid cell fusion in the early phase of Friend virus leukemogenesis.
    Behringer RR; LoCascio NJ; Dewey MJ
    J Natl Cancer Inst; 1987 Sep; 79(3):601-3. PubMed ID: 3476795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired macrophage function in Friend virus leukemia: restoration by statolon.
    Levy MH; Wheelock EF
    J Immunol; 1975 Mar; 114(3):962-5. PubMed ID: 1167568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Friend virus (FVP)-induced murine erythropoiesis with prostaglandin (PGF2 alpha): potentiation and inhibition of erythropoietin and prevention of both with PGD2.
    Lewis JP; Moores RR; Neal WA; Garver FA; Lutcher CL; Zucali JR; Mirand EA
    Exp Hematol; 1981 May; 9(5):540-9. PubMed ID: 6940758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friend erythroleukemia virus complex: role of viral components in modifying erythroid differentiation in mice.
    Fagg B; Ostertag W
    J Natl Cancer Inst; 1982 Mar; 68(3):457-60. PubMed ID: 6950173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of the spleen in Friend virus (F-MuLV-P) erythroleukemia.
    Kreja L; Seidel HJ
    Exp Hematol; 1985 Aug; 13(7):623-8. PubMed ID: 3861325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nature of the target cells for Rauscher and Friend leukemia viruses].
    Sanin AV; Khorobrykh VV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (8):5-20. PubMed ID: 6996749
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage-induced reversal of immunosuppression by leukemia viruses.
    Specter SC; Bendinelli M; Ceglowski WS; Friedman H
    Fed Proc; 1978 Jan; 37(1):97-101. PubMed ID: 201505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications.
    Johnson CS; Chang MJ; Furmanski P
    Blood; 1988 Dec; 72(6):1875-83. PubMed ID: 3196871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of erythropoiesis and hormone sensitivity by RNA tumor viruses.
    Hankins WD; Kaminchik J
    Prog Clin Biol Res; 1984; 148():141-52. PubMed ID: 6589645
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin control of terminal erythroid differentiation: maintenance of cell viability, production of hemoglobin, and development of the erythrocyte membrane.
    Koury MJ; Bondurant MC; Atkinson JB
    Blood Cells; 1987; 13(1-2):217-26. PubMed ID: 3478108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines.
    Shibuya T; Mak TW
    J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.